Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects.

Metcalfe JZ, Cattamanchi A, Vittinghoff E, Ho C, Grinsdale J, Hopewell PC, Kawamura LM, Nahid P.

Am J Respir Crit Care Med. 2010 Jan 1;181(1):87-93. doi: 10.1164/rccm.200906-0981OC. Epub 2009 Oct 1.

2.

Characteristics of IFN-γ responses in IGRA among pulmonary TB suspects in a TB-endemic area.

Feng JY, Huang SF, Lee MC, Ting WY, Chen YC, Lin YY, Lee YC, Su WJ.

Diagn Microbiol Infect Dis. 2013 Sep;77(1):46-52. doi: 10.1016/j.diagmicrobio.2013.05.020. Epub 2013 Jul 16.

PMID:
23867329
3.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
4.

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25.

5.

[Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].

Oztürk N, Sürücüoğlu S, Ozkütük N, Gazi H, Akçali S, Köroğlu G, Ciçek C.

Mikrobiyol Bul. 2007 Apr;41(2):193-202. Turkish.

PMID:
17682705
6.

Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.

Wyndham-Thomas C, Dirix V, Schepers K, Martin C, Hildebrand M, Goffard JC, Domont F, Libin M, Loyens M, Locht C, Van Vooren JP, Mascart F.

BMC Infect Dis. 2015 Feb 14;15:59. doi: 10.1186/s12879-015-0796-0.

7.

Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden.

Mthiyane T, Rustomjee R, Pym A, Connolly C, Onyebujoh P, Theron G, Dheda K.

Int J Infect Dis. 2015 Jul;36:46-53. doi: 10.1016/j.ijid.2015.05.006. Epub 2015 May 21.

8.

Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls.

Faurholt-Jepsen D, Aabye MG, Jensen AV, Range N, Praygod G, Jeremiah K, Changalucha J, Faurholt-Jepsen M, Jensen L, Jensen SM, Krarup H, Ravn P, Friis H, Andersen AB.

Scand J Infect Dis. 2014 May;46(5):384-91. doi: 10.3109/00365548.2014.885657. Epub 2014 Mar 12.

PMID:
24621055
9.

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fløe A, Fresard I, García-García JM, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Pache G, Rath H, Ringshausen FC, Ruiz AS, Solovic I, Souza-Galvão ML, Widmer U, Witte P, Lange C; TBNET.

Am J Respir Crit Care Med. 2015 May 15;191(10):1176-84. doi: 10.1164/rccm.201502-0232OC.

PMID:
25763458
11.

Interferon gamma release assays: principles and practice.

Lalvani A, Pareek M.

Enferm Infecc Microbiol Clin. 2010 Apr;28(4):245-52. doi: 10.1016/j.eimc.2009.05.012. Epub 2009 Sep 24. Review.

PMID:
19783328
12.

Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.

Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A.

Am J Respir Crit Care Med. 2008 May 15;177(10):1164-70. doi: 10.1164/rccm.200711-1613OC. Epub 2008 Feb 14.

PMID:
18276940
13.

Significance of interferon-gamma response to mitogen in serial QuantiFERON-TB Gold In-Tube assay of routine laboratory practice.

Woo KS, Choi JL, Kim BR, Kim JE, Kim BG, Lee H, Kim KH.

Clin Chim Acta. 2014 Mar 20;430:79-83. doi: 10.1016/j.cca.2013.12.038. Epub 2014 Jan 3.

PMID:
24389051
15.

Consistency of Mycobacterium tuberculosis-specific interferon-gamma responses in HIV-1-infected women during pregnancy and postpartum.

Jonnalagadda SR, Brown E, Lohman-Payne B, Wamalwa D, Farquhar C, Tapia K, Cranmer LM, John-Stewart GC.

Infect Dis Obstet Gynecol. 2012;2012:950650. doi: 10.1155/2012/950650. Epub 2012 Mar 15.

16.

Whole blood interferon-γ release assay is insufficient for the diagnosis of sputum smear negative pulmonary tuberculosis.

Park H, Shin JA, Kim HJ, Ahn CM, Chang YS.

Yonsei Med J. 2014 May;55(3):725-31. doi: 10.3349/ymj.2014.55.3.725. Epub 2014 Apr 1.

17.

Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.

Bergamini BM, Losi M, Vaienti F, D'Amico R, Meccugni B, Meacci M, De Giovanni D, Rumpianesi F, Fabbri LM, Balli F, Richeldi L.

Pediatrics. 2009 Mar;123(3):e419-24. doi: 10.1542/peds.2008-1722.

PMID:
19254978
18.

Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis.

Wlodarczyk M, Rudnicka W, Janiszewska-Drobinska B, Kielnierowski G, Kowalewicz-Kulbat M, Fol M, Druszczynska M.

PLoS One. 2014 Sep 15;9(9):e107208. doi: 10.1371/journal.pone.0107208. eCollection 2014.

19.

Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women.

Jonnalagadda SR, Brown E, Lohman-Payne B, Wamalwa D, Farquhar C, John-Stewart GC.

Int J Tuberc Lung Dis. 2013 Dec;17(12):1552-7. doi: 10.5588/ijtld.13.0239.

20.

Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents.

Kim KH, Lee SW, Chung WT, Kim BG, Woo KS, Han JY, Kim JM.

Korean J Lab Med. 2011 Oct;31(4):271-8. doi: 10.3343/kjlm.2011.31.4.271. Epub 2011 Oct 3.

Supplemental Content

Support Center